Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,450
Out of 5,102 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $123.28 | -2.66% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $84.24 | +54.32% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $74.83 | +47.00% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.43 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $68.94 | -54.67% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $29.98 | +16.74% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $127.25 | +131.83% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $63.95 | +42.30% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $63.10 | -57.21% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $294.17 | -77.22% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $123.28
Upside: -2.66%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $84.24
Upside: +54.32%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $74.83
Upside: +47.00%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.43
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $68.94
Upside: -54.67%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $29.98
Upside: +16.74%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $127.25
Upside: +131.83%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $63.95
Upside: +42.30%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $63.10
Upside: -57.21%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $294.17
Upside: -77.22%